All In Biotech

Drug Trial Radar · NCT04748601

Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 4 Study to Evaluate the Efficacy and Safety of Qudexy(R) XR in the Prevention of Migraine in Children 6 to 11 Years of Age

Last checked: Nov 20, 2026Latest source record: Jan 27, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 132 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

132

Planned (sponsor's estimate)

Start

Feb 19, 2021

Primary completion

Sep 2026

Study completion Sep 2026

Sponsor

Lead sponsor
Upsher-Smith LaboratoriesIndustry
Sponsor type
Industry
First posted
Feb 10, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 6 years, up to 11 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Phase 4 study to evaluate Qudexy XR for the prevention of migraine in children 6 to 11 years of age.

Conditions

  • Migraine Disorders

Interventions

  • Qudexy XRDrug

    Extended-Release Capsule

  • PlaceboDrug

    Qudexy XR Matching capsules

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline (last 28 days Run-In Period) in the monthly number of headache days during the 8-week Maintenance Period based on the diary.Time frame: 16 Weeks

Locations

15 sites in 1 country. Site status is shown where the registry gives one.

  • Upsher-Smith Clinical Trial Site #5

    Birmingham, Alabama · Withdrawn

  • Upsher-Smith Clinical Trial Site #15

    La Jolla, California · Recruiting

  • Upsher-Smith Clinical Trials Site #3

    Aurora, Colorado · Withdrawn

  • Upsher-Smith Clinical Trial Site #1

    Stamford, Connecticut · Completed

  • Upsher-Smith Clinical Trial Site #12

    Loxahatchee Groves, Florida · Withdrawn

  • Upsher-Smith Clinical Trial Site #8

    Orlando, Florida · Withdrawn

  • Upsher-Smith Clinical Trial Site #14

    Tampa, Florida · Recruiting

  • Upsher-Smith Clinical Trial Site #2

    Ann Arbor, Michigan · Withdrawn

  • Upsher-Smith Clinical Trial Site #11

    Jackson, Mississippi · Withdrawn

  • Upsher-Smith Clinical Trial Site #10

    Bridgeton, Missouri · Withdrawn

  • Upsher-Smith Clinical Trial Site #4

    Cincinnati, Ohio · Recruiting

  • Upsher-Smith Clinical Trial Site #6

    Portland, Oregon · Recruiting

  • Upsher-Smith Clinical Trials Site #7

    Springfield, Oregon · Recruiting

  • Upsher-Smith Clinical Trial Site #13

    McAllen, Texas · Withdrawn

  • Upsher-Smith Clinical Trial Site #9

    Huntington, West Virginia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.